Covered recipient · General Payments record
MAGGIE E FOSTER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2022–2024
$2,980.03
- Reported across 191 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $494.65 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $158.59 | 14 |
| Lilly USA, LLC | $132.59 | 8 |
| Novo Nordisk AS | $79.45 | 5 |
| Astellas Pharma US Inc | $29.63 | 2 |
| PFIZER INC. | $28.18 | 2 |
| IDORSIA PHARMACEUTICALS US INC | $18.29 | 1 |
| Amgen Inc. | $16.99 | 1 |
| Esperion Therapeutics, Inc. | $15.82 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.42 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107122288 | CMS |
| ABBVIE INC. | $9.04 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107122290 | CMS |
| ABBVIE INC. | $16.54 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107122292 | CMS |
| ABBVIE INC. | $7.90 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107122294 | CMS |
| ABBVIE INC. | $8.72 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107122296 | CMS |
| ABBVIE INC. | $7.22 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107122298 | CMS |
| ABBVIE INC. | $1.84 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107122300 | CMS |
| ABBVIE INC. | $10.26 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107122302 | CMS |
| ABBVIE INC. | $16.53 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107122304 | CMS |
| ABBVIE INC. | $15.44 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107122306 | CMS |
| ABBVIE INC. | $16.80 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107122308 | CMS |
| ABBVIE INC. | $7.99 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107122310 | CMS |
| ABBVIE INC. | $13.59 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107122312 | CMS |
| ABBVIE INC. | $11.30 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107122314 | CMS |
| Amgen Inc. | $16.99 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117555661 | CMS |
| Astellas Pharma US Inc | $15.16 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139488048 | CMS |
| Astellas Pharma US Inc | $14.47 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139497326 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.11 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086371345 | CMS |
| Esperion Therapeutics, Inc. | $15.82 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129466356 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $18.29 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146768504 | CMS |
| Lilly USA, LLC | $17.61 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135800902 | CMS |
| Lilly USA, LLC | $14.48 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135771676 | CMS |
| Lilly USA, LLC | $22.13 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135802420 | CMS |
| Lilly USA, LLC | $13.85 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135800900 | CMS |
| Lilly USA, LLC | $20.15 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135800904 | CMS |
| Lilly USA, LLC | $8.11 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135771678 | CMS |
| Lilly USA, LLC | $17.09 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135830292 | CMS |
| Lilly USA, LLC | $19.17 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135771674 | CMS |
| Novo Nordisk Inc | $15.92 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100590552 | CMS |
| Novo Nordisk Inc | $17.92 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100527795 | CMS |
| Novo Nordisk Inc | $13.27 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100652123 | CMS |
| Novo Nordisk Inc | $17.47 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100233218 | CMS |
| Novo Nordisk Inc | $14.87 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100462878 | CMS |
| PFIZER INC. | $14.48 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131912531 | CMS |
| PFIZER INC. | $13.70 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131922797 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.